{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T20:01:10Z","timestamp":1699905670746},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.antiviral.2008.01.002","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T08:22:27Z","timestamp":1202199747000},"page":"278-281","source":"Crossref","is-referenced-by-count":6,"title":["R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond"],"prefix":"10.1016","volume":"78","author":[{"given":"Bert","family":"Thys","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando M.","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Andries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raf","family":"Vrijsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Rombaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.01.002_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biologicals.2006.02.007","article-title":"Vaccine-derived polioviruses","volume":"34","author":"Agol","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.antiviral.2008.01.002_bib2","series-title":"The Search for Antiviral Drugs","first-page":"179","article-title":"Discovery of pirodavir, a broad-spectrum inhibitor of rhinoviruses","author":"Andries","year":"1993"},{"key":"10.1016\/j.antiviral.2008.01.002_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01311037","article-title":"Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization","volume":"106","author":"Andries","year":"1989","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2008.01.002_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.36.1.100","article-title":"In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity","volume":"36","author":"Andries","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.002_bib5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2174\/138161206776361129","article-title":"Current status of anti-picornavirus therapies","volume":"12","author":"Barnard","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2008.01.002_bib6","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.48.5.1766-1772.2004","article-title":"In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity","volume":"48","author":"Barnard","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.01.002_bib7","unstructured":"Committee on Development of a Polio Antiviral and its Potential Role in Global Poliomyelitis Eradication, N.R.C. (2006). Exploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop Report. The National Academies Press, Washington, D.C."},{"key":"10.1016\/j.antiviral.2008.01.002_bib8","unstructured":"De Palma, A.M., P\u00fcrstinger, G., Patick, A., Andries, K., Rombaut, B., De Clercq, E., Neyts, J., 2008. Comparative activity of a series of anti-enteroviral compounds against poliovirus replication in vitro. Emerg. Infect. Dis., in press."},{"key":"10.1016\/j.antiviral.2008.01.002_bib9","first-page":"3","article-title":"Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom","volume":"82","author":"Halsey","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2008.01.002_bib10","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1073\/pnas.0700451104","article-title":"Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication","volume":"104","author":"Jiang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.01.002_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.01.002_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.mi.46.100192.003223","article-title":"Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment","volume":"46","author":"McKinlay","year":"1992","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2008.01.002_bib13","first-page":"173","article-title":"Stabilisation of poliovirus with pirodavir","volume":"87","author":"Rombaut","year":"1996","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.antiviral.2008.01.002_bib14","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1021\/jm0202876","article-title":"An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus","volume":"46","author":"Watson","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.01.002_bib15","unstructured":"World Health Assembly, 1988. Global eradication of poliomyelitis by the year 2000: resolution of the 41st World Health Assembly. Resolution WHA 41.28. World Health Organization, Geneva, Switzerland."},{"key":"10.1016\/j.antiviral.2008.01.002_bib16","unstructured":"World Health Organization, 2002. Progress towards the global eradication of poliomyelitis, 2001. Wkly. Epidemiol. Rec. 77, 98\u2013107."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T18:30:07Z","timestamp":1546281007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0166354208000223"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}